Significantly, these pathways include pathways in cancer and the PI3K/AKT signaling pathway, among other pathways, offering valuable understanding into possible mechanisms by which Kirenol might exert its impacts in the context of tumor-related signaling (Fig.1E). Here, AKT1 is linked to neoplasm.